Issue №2-22, 2023

Original article

https://doi.org/10.38025/2078-1962-2023-22-2-66-74

Hardware Plasmapheresis Use for Correction of Aging Biomarkers in Healthy Patients Aged 40–60 Years: an Original Study

View article (Download PDF file)



Download XML file

1 ORCIDIlmira R. Gilmutdinova 1 ORCIDElena Yu. Kostromina 1 ORCIDMaxim Yu. Yakovlev 1 ORCIDInessa Kh. Yafarova 1 ORCIDSvetlana A. Barysheva 1 ORCIDAnatoliy D. Fesyun 2 ORCIDAnton V. Ershov 3 ORCIDAnton V. Ershov 4 ORCIDAlexey A. Moskalev

1National Medical Research Center for Rehabilitation and Balneology
2National Medical Research Center for Rehabilitation and Balneology
3Limited Liability Company “DNKOM”
4Lobachevsky State University of Nizhny Novgorod


ABSTRACT

INTRODUCTION. Due to the demographic aging of the population, the problem of treatment of age-related diseases and prevention of premature aging in modern healthcare has become particularly urgent. One of the most promising approaches is the impact on the molecular mechanisms of aging, including the activation of adaptive systems and suppression of pathological processes in the body. Methods of extracorporeal hemocorrection have proved to be a good idea in this respect.

AIM. To evaluate the effectiveness and safety of hardware plasmapheresis as a technology for correcting aging biomarkers.

MATERIAL AND METHODS. A technique of therapeutic plasmapheresis use was introduced for the correction of aging biomarkers. Twenty-four participants (male and female) aged 40–60 years with an elevated level of one or more aging biomarkers underwent a course of therapeutic plasmapheresis in the daytime hospital. All participants underwent four procedures of therapeutic hardware plasmapheresis once every 3 days with 30 % volume of circulating plasma followed by replacement with colloid (5 % albumin solution) and crystalloid solutions (saline solution) in a 1:3 ratio or only crystalloid solutions.

RESULTS AND DISCUSSION. A comparative evaluation of aging biomarkers before the procedure and 17 and 30 days after hardware plasmapheresis showed that therapeutic plasmapheresis affects the levels of human aging biomarkers in blood. A significant decrease in the levels of such biomarkers as homocysteine, urea, gamma-glutamyl transpeptidase, alkaline phosphatase, creatine phosphokinase, cholinesterase, and uric acid was shown. No significant differences were detected when we performed a comparative assessment of biochemical blood parameters following plasmapheresis with or without albumin replacement on biochemical blood parameters. Stable hemodynamic parameters during plasmapheresis and the absence of adverse reactions in patients confirm the safety and tolerability of the therapeutic plasmapheresis procedure.

CONCLUSION. Implementing this technique into clinical practice will allow the development of approaches to etiotropic therapy of many chronic age-related pathologies. These treatments have the potential to increase life expectancy and improve its quality.


KEYWORDS: aging biomarkers, anti-aging therapy, hemocorrection, plasmapheresis

Acknowledgments: The study had no sponsorship

Conflict of interest:: The authors declare no apparent or potential conflicts of interest related to the publication of this article

For citation:

Gilmutdinova I.R., Kostromina E.Yu., Yakovlev M.Yu., Yafarova I.Kh., Barysheva S.A., Fesyun A.D., Ershov A.V., Isaev A.N., Moskalev A.A. Hardware Plasmapheresis Use for Correction of Aging Biomarkers in Healthy Patients Aged 40–60 Years: an Original Study. Bulletin of Rehabilitation Medicine. 2023; 22(2):66-74. https://doi.org/10.38025/2078-1962-2023-22-2-66-74 (In Russ.).



References:

  1. United Nations Department of Economic and Social Affairs, Population Division (2022). World Population Prospects 2022: Summary of Results. UN DESA/POP/2022/TR/NO. 3. Available at: www.unpopulation.org (accessed 06.03.2023). https://population.un.org/wpp/.2022 (accessed 06.03.2023).
  2. Childs B. G., Durik M., Baker D. J., van Deursen J. M. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nature Medicine. 2015; 21(12): 1424–35. https://doi.org/10.1038/nm.4000.
  3. Guo J., Huang X., Dou L., Yan M., Shen T., Tang W., Li J. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy. 2022; 7(1): 391. https://doi.org/10.1038/s41392-022-01251-0
  4. Zhang L., Pitcher L. E., Yousefzadeh M. J., Niedernhofer L. J., Robbins P. D., Zhu Y. Cellular senescence: a key therapeutic target in aging and diseases. The Journal of Clinical Investigation. 2022; 132(15). https://doi.org/10.1172/JCI158450
  5. Rybtsova N., Berezina T., Kagansky A., Rybtsov S. Can Blood-Circulating Factors Unveil and Delay Your Biological Aging? Biomedicines. 2020; 8(12). https://doi.org/10.3390/biomedicines8120615
  6. Etienne J., Liu C., Skinner C. M., Conboy M. J., Conboy I. M. Skeletal muscle as an experimental model of choice to study tissue aging and rejuvenation. Skeletal Muscle. 2020; 10(1): 4. https://doi.org/10.1186/s13395-020-0222-1
  7. Schmidt J. J., Jahn J., Golla P., Hafer C., Kielstein J. T., Kielstein H. Effect of therapeutic plasma exchange on plasma levels and total removal of adipokines and inflammatory markers. BMC Obesity. 2015; (2): 37. https://doi.org/10.1186/s40608-015-0067-z
  8. Mehdipour M., Mehdipour T., Skinner C. M., Wong N., Liu C., Chen C. C., Jeon O. H., Zuo Y., Conboy M. J., Conboy I. M. Plasma dilution improves cognition and attenuates neuroinflammation in old mice. GeroScience. 2021; 43(1): 1–18. https://doi.org/10.1007/s11357-020-00297-8
  9. Rebo J., Mehdipour M., Gathwala R., Causey K., Liu Y., Conboy M. J., Conboy I. M. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nature Communications. 2016; (7): 13363. https://doi.org/10.1038/ncomms13363
  10. Li X., Zhang J., Sun C., Zhang Y., Cai R., Fu S., Zheng J., Huang D. Application of biological age assessment of Chinese population in potential anti-ageing technology. Immunity & Ageing. 2018; (15): 33. https://doi.org/10.1186/s12979-018-0140-9
  11. Gilmutdinova I. R., Eremin P. S., Kostromina E.Iu., Markov P. A., Iafarova I. K., Gilmutdinov R. G., Isaev A. N., Moskalev A. A., Ershov A. V., Rachin A. P., Fesyun A. D. Method for Performing Hardware Plasmapheresis Procedures with Circulating Plasma Volume Replacement for Correcting Biological Age in Healthy People 40–55 Years Old. Patent RF no. 2788817, 2023. (In Russ.).
  12. Gilmutdinova I., Kudryashova I., Kostromina E., Yafarova I., Gilmutdinov R., Kaverina I., Isaev A., Moskalev A. The use of therapeutic plasmapheresis in preventive and sports medicine. BIO Web of Conferences. 2022; (48): 01009. https://doi.org/10.1051/bioconf/20224801009
  13. Jakubowski H. Homocysteine Modification in Protein Structure/Function and Human Disease. Physiological Reviews. 2019; 99(1): 555–604. https://doi.org/10.1152/physrev.00003.2018
  14. Whitfield J. B. Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences. 2001; 38(4): 263–355. https://doi.org/10.1080/20014091084227
  15. Sumien N., Shetty R. A., Gonzales E. B., Creatine, Creatine Kinase, and Aging, in Biochemistry and Cell Biology of Ageing: Part I Biomedical Science, J.R. Harris and V. I. Korolchuk, Editors. Springer Singapore. Singapore. 2018: 145–168.
  16. Wu J., Liu X. H., Huang R., Wu H. S., Guo Q. Y., Yi C. Y., Yu X. Q., Yang X. Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients. Chinese Medical Journal. 2019; 132(2): 232–236. https://doi.org/10.1097/CM9.0000000000000019
  17. So A., Thorens B. Uric acid transport and disease. The Journal of Clinical Investigation. 2010; 120(6): 1791–9. https://doi.org/10.1172/JCI42344
  18. Mehdipour M., Etienne J., Liu C., Mehdipour T., Kato C., Conboy M., Conboy I., Kiprov D. D. Attenuation of age-elevated blood factors by repositioning plasmapheresis: A novel perspective and approach. Transfusion and Apheresis Science. 2021; 60(3): 103162. https://doi.org/10.1016/j.transci.2021.103162
  19. Gilmutdinova I. R., Kudryashova I. S., Kostromina E.Yu., Yakovlev M.Yu., Yafarova I.Kh., Gilmutdinov R. G., Kaverina I. A., Ershov A. V., Isaev A. N., Moskalev A. A. Modern Approaches to Diagnostics and Correction of Aging. Bulletin of Rehabilitation Medicine. 2021; 20(6): 96–102. https://doi.org/10.38025/2078-1962-2021-20-6-96-102 (In Russ.).
  20. Ostrakhovitch E. A., Tabibzadeh S. Homocysteine and age-associated disorders. Ageing Research Reviews. 2019; (49): 144–164. https://doi.org/10.1016/j.arr.2018.10.010
  21. Guo S. M., Liu Y. T., He S. R., Wu M. S., Tseng W. T., Wu R. C., Wu I. C. Differential relationship of uric acid to mortality and clinical biomarkers of aging according to grip strength in older adults: a cohort study. Aging. 2021; 13(7): 10555–10583. https://doi.org/10.18632/aging.202820




Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.